
Eli Lilly Bolsters Pain Management Portfolio with SiteOne Therapeutics Acquisition
Eli Lilly to Acquire SiteOne Therapeutics in $1 Billion Deal to Advance Non-Opioid Pain Therapy In a strategic move aimed at strengthening its neuroscience and pain management portfolio, Eli Lilly…












